Article
The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.
Clinical endocrinology - 1 Sept 2005
Xing Mingzhao
Abstract excerpt
OBJECTIVE: Familial nonmedullary thyroid cancer (FNMTC) is relatively common but its predisposing genetic alteration is unclear. As the somatic T1799A BRAF mutation is highly prevalent in papillary thyroid cancer, the aim was to test whether this mutation was a susceptibility mutation for FNMTC. SUBJECTS AND METHODS: The T1799A BRAF mutation as a possible germline mutation was examined in 40 subjects from 23...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
